Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome
Status:
Suspended
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of topiramate compared to placebo in
the treatment of obesity in metabolic syndrome. Secondary objectives include topiramate and
weight loss effects on lipid levels, HbA1C, insulin resistance, and blood pressure.
Phase:
Phase 3
Details
Lead Sponsor:
Northeastern Ohio Universities College of Medicine
Collaborators:
Akron General Medical Center Aultman Health Foundation Forum Health Mercy Medical Center St. Elizabeth Health Center